New treatment option for Hypertension in Pregnancy
Official title Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health
ClinicalTrials.gov ID: NCT06773299
What this study is testing
- What it's testing
- The purpose of the ENHANCE-CVH study is to promote intergenerational cardiovascular health (CVH) of women and children in Abuja and the surrounding Federal Capital Territory of Nigeria. The study team plans to achieve this through an adaptation of an existing evidence based intervention - Parents as Teachers (PAT) curriculum + Healthy Eating Active Living Taught at Home (HEALTH) - among pregnant women with obesity and their children in Nigeria.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- ≥18 years of age,
- Pregnant women under 14 weeks gestation,
- Singleton gestation,
- Body mass index \> 30 kg/m2
- Willing to participate in ENHANCE CVH for 2 years,
You likely can't join if
- Current enrollment in a weight loss program,
- Inability to engage in a walking program,
- Active substance abuse
- Treatment with medications known to impact weight (e.g., corticosteroids, antipsychotics),
- Plan to relocate within the next 2 years, or
- Unwilling to provide informed consent.
See the full eligibility criteria
- ≥18 years of age,
- Pregnant women under 14 weeks gestation,
- Singleton gestation,
- Body mass index \> 30 kg/m2
- Willing to participate in ENHANCE CVH for 2 years,
- Planning to receive prenatal care and deliver at either one of the participating primary healthcare, centers or University of Abuja Teaching Hospital, and
- Able to give informed consent for study participation, understanding she and her child will both be involved.
- Current enrollment in a weight loss program,
- Inability to engage in a walking program,
- Active substance abuse
- Treatment with medications known to impact weight (e.g., corticosteroids, antipsychotics),
- Plan to relocate within the next 2 years, or
- Unwilling to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Abuja, Nigeria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Abuja, Nigeria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.